Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Recruiting · NCT04633239 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer | Recurrent Ovarian High Grade Serous Adenocarcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma | Recruiting | Phase 1 | 2026-09-11 | NCT04633239 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.